Park Ha Biological Technology Co., Ltd.
PHH
$0.57
-$0.0107-1.84%
NASDAQ
| 10/31/2024 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 79.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 79.25% | |||
| Cost of Revenue | 0.00% | -1.02% | |||
| Gross Profit | 0.00% | 89.67% | |||
| SG&A Expenses | 0.00% | 11.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 8.81% | |||
| Operating Income | 0.00% | 659.09% | |||
| Income Before Tax | 0.00% | 651.29% | |||
| Income Tax Expenses | 0.00% | 509.01% | |||
| Earnings from Continuing Operations | 0.00% | 776.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 776.73% | |||
| EBIT | 0.00% | 659.09% | |||
| EBITDA | 0.00% | 588.03% | |||
| EPS Basic | 0.00% | 760.00% | |||
| Normalized Basic EPS | 0.00% | 633.33% | |||
| EPS Diluted | 0.00% | 760.00% | |||
| Normalized Diluted EPS | 0.00% | 633.33% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||